The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy - Editors' reply

Lancet Diabetes Endocrinol. 2015 Mar;3(3):168-9. doi: 10.1016/S2213-8587(15)00007-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*

Substances

  • Hypoglycemic Agents